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ABSTRACT
Spectral Analysis of Sargassum ilicifolium (Turner) C. Agardh 
and in vitro Anti-proliferative Study of its Ethanolic Extract and 
Chloroform Fraction Against Colon Cancer (HT-29) and Lung 
Cancer (A549) Cell Lines.
Current research in drug discovery from medicinal plants 
involves the identification of safe and inexpensive lead molecule 
towards diseases. Cancer is a second major national burden 
leading to cause death. Reducing the nation’s cancer burden is 
a great challenge to win the “War of cancer”. During the last 
decades, numerous novel compounds have been found from 
marine organisms with interesting pharmaceutical activities. 
Hence, a novel brown algae, Sargassum ilicifolium (Turner) 
C.Agardh belonging to Sargassaceae family has selected and 
the study was aimed to investigate the in vitro anti-proliferative 
activity of ethanolic extract and chloroform fraction of 
Sargassum ilicifolium (Turner) C.Agardh. against colon cancer 
(HT-29) and lung cancer (A549) cell lines. Extraction of seaweed 
using 70% ethanol and fractionated with various solvents. Based 
on phytochemical screening, chloroform fraction was selected, 
then it was subjected to GC-MS analysis. The 70% ethanolic 
exract and chloroform fraction were selected to in vitro MTT 
cell line assay using colon cancer cell line (HT-29) and lung 
cancer cell line (A549). The GC-MS analysis report confirmed 
the presence of 21 compounds and in the the invitro assay, 
IC50value showed the effective anti-proliferative activity against 
colon and lung cancer cell lines. The results of the present study 
proved the anti-proliferative effect of Sargassum ilicifolium. 
Further, the active biomolecule in the fraction has to be isolated 
and charecterized the formulated product subjected to in vivo 
study to strengthen the anticancer activity.
Key Words: Antiproliferative effect, colon cancer, lung cancer, 
Sargassum ilicifolium, GC-MS analysis.
M. Sumithra, V. Chitra, Radika Ramasamy
Department of Pharmacology, SRM College Of Pharmacy, SRM University, 
Kattankulathur, Tamil Nadu, India
Corresponding Author:
M. Sumithra
e-mail: sumi26379@gmail.com
Submitted / Gönderilme: 22.08.2016 Revised / Düzeltme: 03.11.2016
Accepted / Kabul: 22.11.2016
M. Sumithra, V. Chitra, Radika Ramasamy
Spectral Analysis of Sargassum ilicifolium (Turner) C.Agardh and in vitro 
Anti-proliferative Study of its Ethanolic Extract and Chloroform Fraction 
Against Colon Cancer (HT-29) and Lung Cancer (A549) Cell Lines.
1. INTRODUCTION
Today, cancer still remains an aggressive killing disease 
worldwide, however novel synthetic chemotherapeutic 
agents are use clinically but have not succeeded in fulfilling 
the expectations, so development of new anti-cancer drugs 
are needed [1]. Past 30 years the natural sources have received 
more attention for their active constituents for developing a 
new anti-cancer drugs [2,3]. In another side there is increasing 
the strong evidence for plant derived compounds inhibiting 
the various stages of cancer and associated inflammatory 
process. In cancer treatment 60% of drugs are isolated from 
the natural sources [4]. Out of 121 prescription drugs in use 
today for cancer treatment, 9 are derived from plant species. 
In the period of 1981 to 2002, 48 of 65 drugs approved for the 
therapy of cancer were based on natural products [5]. High 
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death rate associated with cancer and serious side effects of 
chemotherapy and radiation therapy many cancer patients 
seek alternative medicine. Now a days various therapies 
are available for treatment of cancer such as chemotherapy, 
radiotherapy but plant phytotherapy plays important role in 
the treatment of cancer.
Sargassum ilicifolium (Turner) C.Agardh belongs to the 
family Sargassaceae is a brown algae having photosynthetic 
pigments such as chlorophyll, carotene, steroids, terpenoids 
mannitol, polysaccharides, alginic acid and it also contains 
algin in cell wall and the cells shows plastid of thyalkoidal 
lamellae [6-8]. Marine algae recognized as rich sources of 
structurally diverse biologically active compounds with great 
pharmaceutical and biomedical potential. Many literature 
survey have been reported that marine algae have various 
important pharmacological activities such as neuroprotective 
activity, anti-viral activity, cholinesterase inhibitor activity 
[9-11].
In the current study we examined the effect of ethanolic 
extract and chloroform fraction of brown marine algae S. 
ilicifolium against colon cancer cell line (HT-29), and lung 
cancer (A549) cell lines over MTT assay. The chloroform 
fraction were subjected into spectral analysis for find out the 
phytochonstituents present in it.
2. MATERIALS AND METHODS
2.1 Chemicals and reagents
MEM was purchased from Hi Media Laboratories. 
Fetal Bovine Serum (FBS) was purchased from Cistron 
Laboratories. Trypsin, methyl thiazolydiphenyltetrazolium 
bromide (MTT) and dimethyl sulfoxide (DMSO) were 
purchased form Sisco Research Laboratory Chemicals 
(Mumbai). All of other chemicals and reagents were obtained 
from Sigma Aldrich (Mumbai).
2.2 Pharmacognostic study
Sargassum ilicifolium (Turner) C.Agardh was collected 
form Mandabam coast, Rameshwaram and aunthetified 
by Professor. Jeyaraman, Director, Plant Anatomy 
Research Centre, Tambaram, Chennai. Certificate No. 
PARC/2011/1032.
2.3 Extraction
The Coarse powder was extracted using ethanol (70% 
v/v) by percolation method and the percentage yield was 
calculated. The ethanolic extract was subjected to defatting 
with petroleum ether then fractionated with chloroform. The 
chloroform fraction was subjected to GC-MS analysis.
2.4 GC-MS Analysis [12]
2µl of the liquid chloroform fraction of Sargassum ilicifolium 
employed for GC-MS for analysis of different compounds. 
Instruments and chromatographic conditions was carried 
out on a clarus 500 Perkin Elmer system comparising a 
AOC-20i auto sampler and gas chromatograph interfaced 
to a mass spectrometer instrument employing the standard 
protocol and the interpretation of phytomolecule present was 
performed using National Institute Standard and Technology 
(NIST) data base.
3 Pharmacological screening
3.1 In vitro cytotoxic studies
3.1.1 Cell line and culture
HT-29 and A 549 cell lines were purchased from National 
Centre for Cell Science, Pune (NCCS). The cells were 
maintained in Minimal Essential Medium supplemented with 
10% FBS, penicillin (100u/ml) and streptomycin (100µg/ml) 
in a humidified atmosphere of 50 µg/ml CO2 at 37oC.
3.1.2 In vitro assay for Anti-cancer activity (MTT assay) 
(Moamann, 1983) [13]
Cells (1 x 105/well) were plated in 24-well plates and incubated 
in 370C with 5% of CO2 condition. After the cell reaches the 
confluence, the various concentrations of the samples were 
added and incubated for 24 hrs. After incubation, the sample 
was removed from the well and washed with phosphate-
buffered saline (pH 7.4) or MEM without serum. 100µl/
well (5mg/ml) of 0.5% 3-(4,5-dimethlyl-2-thiazolyl)-2,5-
diphenyl-tetrazolium bromide (MTT) wsas added and 
incubated for hours. After incubation, 1ml of DMSO was 
added in all the wells. The absorbance was measured at 
570nm with UV-spectrophotmeter using DMSO as the 
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blank. All the measurements were performed and the 
concentration required for a 50% inhibition (IC50) was 
determined graphically. The % cell viability was calculated 
using the following formula
%cell viability=A570 of treated cells/A570 of control cells 
x 100
Graphs are plotted using the % of cell viability at Y-axis and 
concentration of sample in X-axis. Cell control and sample 
control is included in each assay to compare the full cell 
viability assessments.
4. RESULTS & DISCUSSION
The percentage yield of ethanolic extract and chloroform 
fraction of Sargassum ilicifolium were found to be 5.03% 
and 0.48% respectively. Phytochemical analysis revealed the 
presence of alkaloids, steroids, terpenoids, fatty acid, saponins 
and tannins in the ethanolic extract and in chloroform 
fraction steroids, fatty acid and tannins were present.
Literature study supports that steroid and fatty acids 
are having potent role in cytotoxicity. The chloroform 
fraction subjected to GC-MS analysis confirmed the 
presence of 21 compounds namely 1-hexadecene, 
1-octadecene,16-octadecenoic acid methyl ester, 
10-nonadecanone, 9-hexadecenoic acid methyl ester, 
14-methylpentadecanoic acid methyl ester, 10-octadecenoic 
acid methyl ester, 5,8,11,14-eicosatetraenoic acid methyl 
ester, 11-eicosenoic acid methyl ester, 1-tricosene, 
18-nonadecenaic acid, 17-methly octadecanoic acid methyl 
ester, 2-hexadecanol, 5-hydroxypentanoicacid 2,4-di-
t-butylphenyl esters, hexadecane, 9-hexylheptadecane, 
2,6,10-trimethyltetradecane, 7,10-octadecanoic acid 
methyl ester, 1-monolinoleoyl glycerol trimethylsilyl ether, 
6,17,21-tris[{trimethylsilyl}]-3,20-bis(O-methyloxime)
pregn-4-ene-3,11,20-trione (Table1). The GC-MS 
spectroscopic studies confirmed the presence of eicosaenoic 
acid derivatives and steroids which are of biological 
importance.
MTT assay is performed to assess the cell viability. The 
principle involved in the assay is the reduction of MTT 
tetrazolium dye to insoluble purple colour formazan by 
NAD(P)H-dependent cellular oxido-reductase enzymes 
under defined conditions and it directly reflects the number 
of viable cells present in it. The quantity of formazan formed 
was measured at 570 nm using spectrophotometer [14].
The percentage cell viability by the extract and fraction of 
S. ilicifolium against HT-29 (colon cancer cell line) were 
listed in the Table 2 and Figure 2 and the A549 cell line 
(lung cancer cell line) result were listed out in the Table 3 
and Figure 3 for various concentrations respectively. The 
IC50value for ethanolic extract and chloroform fraction of S. 
ilicifolium against HT-29 cell line was found to be 14.14µg/ml 
and 15.22µg/ml respectively and the IC50 value against A549 
was found to be 31.2µg/ml and 7.8µg/ml respectively. The 
50% inhibition of human cancer cell lines by the extract and 
chloroform fraction of S. ilicifolium elicits the cytotoxicity 
role against colon and breast cancer cell lines. The results 
concludes that the chloroform fraction was very effective 
against lung cancer cell line than colon cancer.
Figure 1: GC-MS analysis data of chloroform fraction of 
Sargassum ilicifolium
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Table 1: Phytochemical identified in the ethanol extract of Sargassum ilicifolium by GC-MS peak report.
S. No Compounds RT M+ Mass spectral data, m/z Mol. Formula
1 1-Hexadecene 13.33 224 224, 196, 154, 140, 125, 
111, 97, 55
C16 H32
2 1-Octadecene 15.65 252 252, 224, 154, 111, 97, 83, 
69, 55
C18H36
3 16-Octadecenoic acid methyl ester 16.03 296 296, 267, 256, 221, 207, 
147, 111, 87, 73
C19H36O2
4 10-Nonadecanone 16.53 282 282, 254, 223, 183, 170, 
155, 149, 127, 110, 85, 
71,  57
C19H38O
5 9-Hexadecenoic acid methyl ester 16.85 268 268, 236, 194, 152, 123, 
110,  97,  87,  69,  55
C17H32O2
6 14-methylpentadecanoic acid methyl ester 17.73 270 270, 239, 227, 111, 87, 
74,  57
C17H34O2
7 10-Octadecenoic acid methyl ester 18.87 296 292, 264, 222, 123, 98, 83, 
69, 55
C19H36O2
8 Ethyl oleate 19.45 310 310, 264, 180, 123, 101, 
88, 69, 55
C20H38O2
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S. No Compounds RT M+ Mass spectral data, m/z Mol. Formula
9 5,8,11,14-Eicosatetraenoic acid methyl ester 20.32 318 318, 247, 180, 150, 105, 
91, 79,  67
C21H34O2
10 11-Eicosenoic acid methyl ester 20.65 324 324, 292, 250, 208, 111, 
97, 69, 55
C21H40O2
11 1-Tricosene 21.43 336 336, 322, 125, 111, 97, 83, 
69, 57
C23H46
12 18-Nonadecenaic acid 22.57 278 278, 236, 194, 125, 111, 
97, 83, 69, 55
C19H38O2
13 17-methyloctadecanoic acid methyl ester 22.88 312 312, 269, 199, 143, 111, 
87, 74
C20H40O2
14 2-Hexadecanol 23.67 242 242, 176, 125, 111, 97, 
83, 69
C16H34O
15 5-hydroxypentanoic acid 2,4-di-t-butylphenyl ester 12.52 306 306, 191, 163, 91, 74, 57 C19H30O3
16 Hexadecane
CH3 CH3
13.43 226 226, 183, 141, 99, 85, 71, 
57
C16H34
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S. No Compounds RT M+ Mass spectral data, m/z Mol. Formula
17 9-hexylheptadecane 15.22 291 291, 276, 252, 230, 197, 
183, 163, 127, 113, 99, 85, 
71, 57
C23H48
18 2,6,10-trimethyltetradecane 16.78 240 240, 225, 155, 113, 99, 85, 
71, 57
C17H36
19
10-Octadecenoic acid methyl ester 18.8 296 296, 263, 220, 178, 150, 
121, 109, 95, 81, 67
C19H36O2
20 1-Monolinoleoyl glycerol trimethylsilyl ether 17.63 498 498, 383, 355, 341, 295, 
281, 207, 147, 113, 99, 73
C27H54O4Si2
21 Steroids
6,17,21-tris[{trimethylsilyl}oxyl]-3,20-bis(O-methyloxime) 
pregn-4-ene-3,11,20-trione
23.37 529 529, 439, 355, 246, 168, 
147, 113, 85, 73
C32H58N2 O6Si3
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Table 2: Anti-cancer activity of chloroform fraction and ethanolic extract of Sargassum ilicifolium on HT-29 cell line
S. No Concentration (µg/ml) Dilutions Absorbance 
(O.D) of chloroform fraction
Cell viability (%)of 
chloroform fraction
Absorbance (O.D) of 
ethanolic extract
Cell viability (%) of 
ethanolic extract.
1 1000 Neat 0.09 14.28 0.05 7.93
2 500 1:1 0.12 19.04 0.11 17.46
3 250 1:2 0.15 23.80 0.17 26.98
4 125 1:4 0.19 30.15 0.21 33.33
5 62.5 1:8 0.22 34.92 0.28 44.44
6 31.2 1:16 0.27 42.85 0.30 47.61
7 15.6 1:32 0.31 49.20 0.33 52.38
8 7.8 1:64 0.34 53.96 0.35 55.55
9 Cell control - 0.63 100 0.63 100
Table 3: Anti-cancer activity of ethanolic extract and chloroform fraction of Sargassum ilicifolium on A549 cell line
S.No Concentration (µg/ml) Dilutions Absorbance  
(O.D)ethanolic extract
Cell viability (%) of 
ethanolic extract
Absorbance (O.D) of 
chloroform fraction
Cel viability (%) of 
chloroform fraction
1 1000 Neat 0.06 10.16 0.02 3.38
2 500 1:1 0.10 16.94 0.05 8.47
3 250 1:2 0.14 23.72 0.00 15.25
4 125 1:4 0.20 33.89 0.13 22.03
5 62.5 1:8 0.26 44.06 0.19 32.20
6 31.2 1:16 0.30 50.84 0.23 38.98
7 15.6 1:32 0.33 55.93 0.28 47.45
8 7.8 1:64 0.37 62.71 0.31 52.54
9 Cell control - 0.59 100 0.59 100
Figure 2. Anticancer effects of ethanolic extract and chloroform fraction of Sargassum ilicifolium on HT-29 cell line.
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Figure 3. Anticancer effects of ethanolic extract and chloroform fraction of Sargassum ilicifolium on A-549 cell line.
5.Conclusion
In vitro cytotoxic studies of the ethanolic extract and 
chloroform fraction against HT-29 (colon cancer cell line) 
and A549 (lung cancer cell line) cell lines supports the anti-
cancer activity of Sargassum ilicifolium. The IC50 value of 
MTT assay on extract and fraction confirms the potency 
against cancer cell lines. Thus further studies has to be 
carried out to strengthen the result by promoting in vivo 
studies and to formulate the isolated compound responsible 
for anticancer activity.
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Sargassum ilicifolium (Turner) C.Agardh’ın Spektral Analizi 
ve Kolon Kanseri (HT-29) ve Akciğer Kanseri (A549) Hücre 
Serilerine Karşı Etanolik Ekstre ve Kloroform Fraksiyonunun 
in vitro Anti-proliferatif Çalışması
ÖZ
Tıbbi bitkilerden ilaç keşfi ile ilgili güncel araştırmalar, 
hastalıklara karşı güvenli ve ucuz öncü molekül tanımlanmasını 
gerektirir. Kanser ölüme neden olan ikinci büyük ulusal bir 
yüktür. “Kanser Savaşı” nı kazanmak için ulusun kanser 
yükünü azaltmak, büyük bir mücadeledir. Son on yılda, 
deniz organizmalarından ilginç farmasötik aktiviteleri ile çok 
sayıda yeni bileşik bulunmuştur. Bu nedenle, bu çalışmada 
Sargassaceae familyasına ait yeni bir kahverengi yosun olan 
Sargassum ilicifolium (Turner) C.Agardh seçilmiş ve Sargassum 
ilicifolium (Turner) C.Agardh’ın etanolik ekstraktı ve kloroform 
fraksiyonunun kolon kanseri (HT-29) ve akciğer kanseri (A549) 
hücre serilerine karşı in vitro anti-proliferatif etkinliğinin 
araştırılması amaçlamıştır. Deniz yosununun ekstraksiyonu 
%70 etanol ve çeşitli çözücüler kullanarak fraksiyonlanmıştır. 
Fitokimyasal taramaya dayanılarak, kloroform fraksiyonu 
seçildi, sonra GC-MS analizine tabi tutuldu. İn vitro MTT hücre 
hattı deneyi için, kolon kanseri hücre hattı (HT-29) ve akciğer 
kanseri hücre hattı (A549) kullanılarak % 70 etanolik ekstrakt 
ve kloroform fraksiyonu seçildi. GC-MS analizi raporunda 21 
bileşiğin varlığı doğrulandı ve in vitro kolon ve akciğer kanseri 
hücre hatlarına karşı anti-proliferatif aktivite etkisi IC50 
değeri ile gösterildi. İleride fraksiyondaki aktif biyomolekül 
izole edilmeli ve antikanser aktivitesini güçlendirmek için in 
vivo incelemeye tabi tutulan formüle edilmiş ürün karakterize 
edilmelidir.
Anahtar Kelimeler: Antiproliferatif etki, kolon kanseri, akciğer 
kanseri, Sargassum ilicifolium, GC-MS analizi.
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